Novartis has carried out a survey to find out what elements of a treatment are most important to patients with psoriasis. The survey found that patients value clear skin the most, but other factors are also important to them. For more detailed information, you can view the source press release here, at Novartis’ website.
Psoriasis is an autoimmune disease that can cause patches of red and flaky skin covered by silvery dead skin cells, amongst other symptoms. The patches are linked to a faster than usual build-up of skin cells. They can occur anywhere, but often appear on the elbows, knees, scalp, and lower back. Some people have comparatively mild symptoms, whereas others experience more severe and painful symptoms that can significantly impact their quality of life.
In order to better understand what patients’ value in treatments, Novartis carried out a survey of three hundred people in the US who have moderate-to-severe psoriasis. They questionnaire was done online, and asked people to indicate which features of a potential treatment would be most important to them.
The study found that patients valued clear skin the most. However, they also emphasised the importance of research showing long-term safety and efficacy and no reactions at the injection site. In addition, people responding to the survey said that it was important for a treatment to effectively treat other manifestations of psoriasis, such as on the scalp, hands, feet, and psoriatic arthritis. According to the survey the number of injections per dose and how frequently the doses need to be given are less important to patients.
Dr Khalil from Novartis says that this survey will help the company to “better understand what patients need.”